Suchergebnisse - "Alzheimer Disease/cerebrospinal fluid"

Contactin proteins in cerebrospinal fluid show different alterations in dementias

Autoren: Besnik Muqaku Sarah Anderl-Straub Leonie Werner et al.

Quelle: J Neurol
Journal of neurology 271(12), 7516-7524 (2024). doi:10.1007/s00415-024-12694-6

Schlagwörter: Male, Lewy Body Disease, Synaptic dysfunction, cerebrospinal fluid [Lewy Body Disease], cerebrospinal fluid [Frontotemporal Dementia], Mass Spectrometry, cerebrospinal fluid [Contactins], diagnosis [Frontotemporal Dementia], Contactins, Alzheimer Disease, cerebrospinal fluid [Parkinson Disease], Contactin, Humans, ddc:610, Aged, Aged, 80 and over, Original Communication, cerebrospinal fluid [Dementia], diagnosis [Alzheimer Disease], Parkinson Disease, Biomarker, Middle Aged, Aged, 80 and over [MeSH], Aged [MeSH], Lewy Body Disease/cerebrospinal fluid [MeSH], Lewy Body Disease/diagnosis [MeSH], Dementia/diagnosis [MeSH], Cerebrospinal fluid, Frontotemporal Dementia/diagnosis [MeSH], Alzheimer Disease/diagnosis [MeSH], Alzheimer's disease, Male [MeSH], Frontotemporal Dementia/cerebrospinal fluid [MeSH], Mass Spectrometry [MeSH], Dementia, Female [MeSH], Humans [MeSH], Dementia/cerebrospinal fluid [MeSH], Middle Aged [MeSH], Parkinson Disease/diagnosis [MeSH], Biomarkers/cerebrospinal fluid [MeSH], Contactins/cerebrospinal fluid [MeSH], Parkinson Disease/cerebrospinal fluid [MeSH], Alzheimer Disease/cerebrospinal fluid [MeSH], diagnosis [Dementia], cerebrospinal fluid [Alzheimer Disease], cerebrospinal fluid [Biomarkers], Frontotemporal Dementia, Female, diagnosis [Lewy Body Disease], diagnosis [Parkinson Disease], Biomarkers

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39317877
https://pure.amsterdamumc.nl/en/publications/7b035f3c-0ba0-49a7-bd8c-5799d4d0172b
https://doi.org/10.1007/s00415-024-12694-6
https://repository.publisso.de/resource/frl:6521897

Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF‐AD study

Autoren: Smith, Rebecca G. Pishva, Ehsan Kouhsar, Morteza et al.

Weitere Verfasser: Smith, Rebecca G. Pishva, Ehsan Kouhsar, Morteza et al.

Quelle: Alzheimers Dement
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Alzheimer's & dementia, vol. 20, no. 10, pp. 6722-6739
Alzheimer's & dementia

Schlagwörter: Male, Neurofilament light (NfL), Methylation quantitative trait loci (mQTL), Neurofilament Proteins, neurofilament light (NfL), tau, BRAIN, DNA methylation, Cerebrospinal fluid (CSF), Genome-wide association study (GWAS), DEMENTIA, METHYLATION, amyloid, Middle Aged, 3. Good health, [SDV] Life Sciences [q-bio], Blood, mild cognitive impairment (MCI), Alzheimer's disease (AD), epigenome-wide association study (EWAS), biomarker, Epigenetics, Female, Life Sciences & Biomedicine, Neurovetenskaper, DNA Methylation/genetics, PACKAGE, Research Article, Chitinase-3-Like Protein 1/cerebrospinal fluid, Amyloid, YKL-40, Clinical Neurology, BETA, cerebrospinal fluid (CSF), DIAGNOSIS, methylation quantitative trait loci (mQTL), epigenome‐wide association study (EWAS), blood, Alzheimer Disease, Humans, Alzheimer Disease/genetics, Alzheimer Disease/blood, Alzheimer Disease/cerebrospinal fluid, Chitinase-3-Like Protein 1/genetics, Chitinase-3-Like Protein 1/blood, Biomarkers/cerebrospinal fluid, Biomarkers/blood, Neurofilament Proteins/cerebrospinal fluid, Neurofilament Proteins/blood, Aged, Genome-Wide Association Study, YKL‐40, epigenetics, genome‐wide association study (GWAS), protein quantitative trait loci (pQTL), Chitinase-3-Like Protein 1, METAANALYSIS, Protein quantitative trait loci (pQTL), Science & Technology, IDENTIFICATION, Neurosciences, 3202 Clinical sciences, 1103 Clinical Sciences, Biomarker, genome-wide association study (GWAS), DNA Methylation, NEUROGRANIN, Geriatrics, 5202 Biological psychology, 3209 Neurosciences, Epigenome-wide association study (EWAS), Human medicine, Neurosciences & Neurology, TAU, Tau, NEUROPATHOLOGY, 1109 Neurosciences, Mild cognitive impairment (MCI), Biomarkers

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39193893
https://serval.unil.ch/resource/serval:BIB_8DB8DBD5DA45.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_8DB8DBD5DA45
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_8DB8DBD5DA452
https://repository.uantwerpen.be/docstore/d:irua:25710
https://hdl.handle.net/10067/2087850151162165141
https://biblio.vub.ac.be/vubir/blood-dna-methylomic-signatures-associated-with-csf-biomarkers-of-alzheimers-disease-in-the-emifad-study(1759a547-2aa6-472d-85b1-6a3d0b2aed2b).html
http://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-115683

CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease

Autoren: Delvenne, Aurore Gobom, Johan Schindler, Suzanne E. et al.

Weitere Verfasser: Delvenne, Aurore Gobom, Johan Schindler, Suzanne E. et al.

Quelle: Alzheimers Dement
Delvenne, A, Gobom, J, Schindler, S E, Kate, M T, Reus, L M, Dobricic, V, Tijms, B M, Benzinger, T L S, Cruchaga, C, Teunissen, C E, Ramakers, I, Martinez-Lage, P, Tainta, M, Vandenberghe, R, Schaeverbeke, J, Engelborghs, S, Roeck, E D, Popp, J, Peyratout, G, Tsolaki, M, Freund-Levi, Y, Lovestone, S, Streffer, J, Barkhof, F, Bertram, L, Blennow, K, Zetterberg, H, Visser, P J & Vos, S J B 2024, 'CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease', Alzheimer's and Dementia, vol. 20, no. 9. https://doi.org/10.1002/alz.14103
Alzheimer's & dementia, vol. 20, no. 9, pp. 6205-6220
Alzheimer's & dementia

Schlagwörter: Male, Proteomics, 0301 basic medicine, Hippocampus, Alzheimer Disease/cerebrospinal fluid, 0302 clinical medicine, Neurofilament Proteins, neurodegeneration markers, neurofilament light, pathophysiology, RISK, neurogranin, ASSOCIATION, Alzheimer's disease, Middle Aged, Humans, Alzheimer Disease/pathology, Biomarkers/cerebrospinal fluid, Neurogranin/cerebrospinal fluid, Female, Aged, Neurofilament Proteins/cerebrospinal fluid, tau Proteins/cerebrospinal fluid, Hippocampus/pathology, Amyloid beta-Peptides/cerebrospinal fluid, Peptide Fragments/cerebrospinal fluid, biomarkers, cerebrospinal fluid, hippocampal volume, proteomics, 3. Good health, Life Sciences & Biomedicine, Research Article, EXPRESSION, Clinical Neurology, tau Proteins, 03 medical and health sciences, CEREBROSPINAL-FLUID, ADULT, Alzheimer Disease, Science & Technology, Amyloid beta-Peptides, 3202 Clinical sciences, 1103 Clinical Sciences, COGNITIVE IMPAIRMENT, Peptide Fragments, NEUROGRANIN, MODEL, Geriatrics, 5202 Biological psychology, 3209 Neurosciences, Neurogranin, Human medicine, Neurosciences & Neurology, TAU, 1109 Neurosciences, Biomarkers

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38970402
https://cris.maastrichtuniversity.nl/en/publications/2316d2b0-5f99-44c6-bbd7-59c2e9394a72
https://doi.org/10.1002/alz.14103
https://research.vumc.nl/en/publications/b96529f8-610d-43a5-9e86-f8fb02e59933
https://ora.ox.ac.uk/objects/uuid:a95f1a7b-5133-47ea-8112-88b7d2b4b3fa
https://doi.org/10.1002/alz.14103
https://lirias.kuleuven.be/handle/20.500.12942/747573
https://doi.org/10.1002/alz.14103
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_B6F71BC8718A9
https://serval.unil.ch/notice/serval:BIB_B6F71BC8718A
https://serval.unil.ch/resource/serval:BIB_B6F71BC8718A.P001/REF.pdf
https://repository.uantwerpen.be/docstore/d:irua:24554
https://hdl.handle.net/10067/2071140151162165141
https://biblio.vub.ac.be/vubir/csf-proteomic-profiles-of-neurodegeneration-biomarkers-in-alzheimers-disease(e862faea-f52c-493d-b939-561c3f36cab0).html
https://discovery-pp.ucl.ac.uk/id/eprint/10194408/

Independent validation and outlier analysis of EuroPOND Alzheimer’s disease staging model using ADNI and real-world clinical data

Autoren: Wittens, Mandy M J Sima, Diana M Brys, Arne et al.

Weitere Verfasser: Wittens, Mandy M J Sima, Diana M Brys, Arne et al.

Quelle: Alzheimers Res Ther
Alzheimer’s Research & Therapy, Vol 17, Iss 1, Pp 1-15 (2025)
Alzheimer's Research & Therapy, Vol. 17, no.1 (2025)
Alzheimer's research & therapy

Schlagwörter: Male, Sciences sociales & comportementales, psychologie, Neuropsychological Tests, Alzheimer Disease/cerebrospinal fluid, Cohort Studies, Alzheimer Disease/pathology, Neurosciences & comportement, 11 Medical and Health Sciences, AMYLOID-PET, Aged, 80 and over, DEMENTIA, Alzheimer's disease, Middle Aged, Mental Status and Dementia Tests, Magnetic Resonance Imaging, MENTAL-STATE-EXAMINATION, Disease Progression, Female, Life Sciences & Biomedicine, RC321-571, Alzheimer Disease/diagnosis, Alzheimer Disease/diagnostic imaging, BIOMARKERS, Clinical Neurology, tau Proteins, Neurosciences. Biological psychiatry. Neuropsychiatry, Cognitive Dysfunction/cerebrospinal fluid, Magnetic resonance imaging, Alzheimer Disease, Humans, Event-based modelling, Biomarkers/cerebrospinal fluid, Cognitive Dysfunction, RC346-429, Aged, Science & Technology, Amyloid beta-Peptides, 42 Health sciences, Neurosciences & behavior, Research, Neurosciences, tau Proteins/cerebrospinal fluid, 32 Biomedical and clinical sciences, Amyloid beta-Peptides/cerebrospinal fluid, HYPOTHETICAL MODEL, Automated volumetry, Social & behavioral sciences, psychology, Human medicine, Neurosciences & Neurology, Neurology. Diseases of the nervous system, Biomarkers

Zugangs-URL: https://doaj.org/article/4ac244a8e3514ea89eac381bed6bba63
https://lirias.kuleuven.be/handle/20.500.12942/769282
https://doi.org/10.1186/s13195-025-01788-6
https://hdl.handle.net/2268/333357
https://doi.org/10.1186/s13195-025-01788-6
https://hdl.handle.net/2078.1/303503
https://hdl.handle.net/10067/2152550151162165141
https://repository.uantwerpen.be/docstore/d:irua:29598

Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition

Autoren: Dayana Hayek Gabriel Ziegler Luca Kleineidam et al.

Weitere Verfasser: Dayana Hayek Gabriel Ziegler Luca Kleineidam et al.

Quelle: Mol Psychiatry
Molecular psychiatry 29(4), 992-1004 (2024). doi:10.1038/s41380-023-02387-3
Hayek, D, Ziegler, G, Kleineidam, L, Brosseron, F, Nemali, A, Vockert, N, Ravichandran, K A, Betts, M J, Peters, O, Schneider, L-S, Wang, X, Priller, J, Altenstein, S, Schneider, A, Fliessbach, K, Wiltfang, J, Bartels, C, Rostamzadeh, A, Glanz, W, Buerger, K, Janowitz, D, Perneczky, R, Rauchmann, B-S, Teipel, S, Kilimann, I, Laske, C, Mengel, D, Synofzik, M, Munk, M H, Spottke, A, Roy, N, Roeske, S, Kuhn, E, Ramirez, A, Dobisch, L, Schmid, M, Berger, M, Wolfsgruber, S, Yakupov, R, Hetzer, S, Dechent, P, Ewers, M, Scheffler, K, Schott, B H, Schreiber, S, Orellana, A, de Rojas, I, Marquié, M, Boada, M, Sotolongo, O, González, P G, Puerta, R, Düzel, E, Jessen, F, Wagner, M, Ruiz, A, Heneka, M T & Maass, A 2024, ' Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition ', Molecular Psychiatry . https://doi.org/10.1038/s41380-023-02387-3

Schlagwörter: Male, tau Proteins, cerebrospinal fluid [Amyloid beta-Peptides], Article, Cohort Studies, pathology [Alzheimer Disease], methods [Magnetic Resonance Imaging], Cognition, pathology [Brain], pathology [Gray Matter], Alzheimer Disease, pathology [White Matter], Humans, Cognitive Dysfunction, ddc:610, Longitudinal Studies, Gray Matter, Aged, Inflammation, 2. Zero hunger, Amyloid beta-Peptides, physiology [Cognition], Brain, Middle Aged, Magnetic Resonance Imaging, White Matter, ddc, 3. Good health, cerebrospinal fluid [Alzheimer Disease], cerebrospinal fluid [Inflammation], cerebrospinal fluid [Cognitive Dysfunction], cerebrospinal fluid [Biomarkers], cerebrospinal fluid [tau Proteins], Neuroscience, Predictive markers, Female, Cognition/physiology [MeSH], Cognitive Dysfunction/cerebrospinal fluid [MeSH], 13/21, Aged [MeSH], 59/57, 692/53/2423, Amyloid beta-Peptides/cerebrospinal fluid [MeSH], Gray Matter/pathology [MeSH], Cohort Studies [MeSH], Male [MeSH], White Matter/pathology [MeSH], tau Proteins/cerebrospinal fluid [MeSH], Female [MeSH], Brain/pathology [MeSH], Humans [MeSH], Longitudinal Studies [MeSH], Middle Aged [MeSH], Biomarkers/cerebrospinal fluid [MeSH], Magnetic Resonance Imaging/methods [MeSH], 631/378, Alzheimer Disease/pathology [MeSH], Inflammation/cerebrospinal fluid [MeSH], article, Alzheimer Disease/cerebrospinal fluid [MeSH], Biomarkers

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38216727
https://resolver.sub.uni-goettingen.de/purl?gro-2/140514
https://hdl.handle.net/20.500.11820/23d98c62-f4e0-49bd-8069-d750bb462b69
https://www.pure.ed.ac.uk/ws/files/408695259/s41380-023-02387-3.pdf
https://pmc.ncbi.nlm.nih.gov/articles/PMC11176056/
https://repository.publisso.de/resource/frl:6498051
https://epub.ub.uni-muenchen.de/117495/
https://mediatum.ub.tum.de/doc/1770249/document.pdf

Transferability of European-derived Alzheimer’s disease polygenic risk scores across multiancestry populations

Autoren: Nicolas, Aude Sherva, Richard Grenier-Boley, Benjamin et al.

Weitere Verfasser: Nicolas, Aude Sherva, Richard Grenier-Boley, Benjamin et al.

Quelle: Nat Genet
Nature genetics 57(7), 1598-1610 (2025). doi:10.1038/s41588-025-02227-w
Nature genetics, vol. 57, no. 7, pp. 1598-1610
EADB, Leonard, H L, Yokoyama, J S, Nalls, M A, Miyashita, A, Hara, N, Ozaki, K, Niida, S, Williams, J, Masullo, C, Amouyel, P, Preux, P-M, Mbelesso, P, Bandzouzi, B, Saykin, A, Jessen, F, Kehoe, P G, van Duijn, C, Ben Salem, N, Frikke-Schmidt, R, Cherni, L, Greicius, M D, Tsolaki, M, Sanchez-Juan, P, Silva, M A R, Porter, T, Laws, S M, Sleegers, K, Ingelsson, M, Dartigues, J F, Seshadri, S, Rossi, G, Morelli, L, Hiltunen, M, Sims, R, van der Flier, W M, Andreassen, O A, Arboleda, H, Cruchaga, C, Escott-Price, V, Qvist Thomassen, J, Ruiz, A, Lee, K H, Ikeuchi, T, Ramirez, A, Gim, J, Logue, M W, Lambert, J C, Nordestgaard, B & Tybjærg-Hansen, A 2025, ' Transferability of European-derived Alzheimer's disease polygenic risk scores across multiancestry populations ', Nature Genetics, vol. 57, no. 7, pp. 1598-1610 . https://doi.org/10.1038/s41588-025-02227-w
In Review
medRxiv

Schlagwörter: Male, Multifactorial Inheritance, Letter, 3001 Agricultural biotechnology, epidemiology [Alzheimer Disease], genetics [White People], genetics [Alzheimer Disease], Alzheimer's disease, genetics, Polymorphism, Single Nucleotide, White People, 3105 Genetics, Medical Genetics and Genomics, EADB, Apolipoproteins E, Alzheimer Disease, Risk Factors, ddc:570, Humans, Genetic Predisposition to Disease, Alzheimer Disease/genetics, Alzheimer Disease/epidemiology, Alzheimer Disease/cerebrospinal fluid, Multifactorial Inheritance/genetics, White People/genetics, Genome-Wide Association Study, Europe/epidemiology, Apolipoproteins E/genetics, Female, Aged, Biomarkers/cerebrospinal fluid, Genetic Risk Score, genetics [Multifactorial Inheritance], 11 Medical and Health Sciences, Genetics & Heredity, Science & Technology, ASSOCIATION, epidemiology [Europe], 06 Biological Sciences, Medicinsk genetik och genomik, 3. Good health, Europe, cerebrospinal fluid [Alzheimer Disease], cerebrospinal fluid [Biomarkers], 3102 Bioinformatics and computational biology, genetics [Apolipoproteins E], Life Sciences & Biomedicine, Biomarkers, Developmental Biology

Dateibeschreibung: application/pdf

Zugangs-URL: https://hdl.handle.net/1871.1/9544cae8-656b-460b-9bda-8dfd97b7ac51
https://doi.org/10.1038/s41588-025-02227-w
https://research.vu.nl/en/publications/9544cae8-656b-460b-9bda-8dfd97b7ac51
https://pub.dzne.de/record/280053
https://resolver.sub.uni-goettingen.de/purl?gro-2/150076
https://serval.unil.ch/resource/serval:BIB_A8B020270FE0.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_A8B020270FE0
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_A8B020270FE08
https://curis.ku.dk/ws/files/460186311/s41588-025-02227-w.pdf
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-565104

Cerebrospinal Fluid Amyloid and Tau Biomarker Changes Across the Alzheimer Disease Clinical Spectrum

Autoren: de Leeuw, Diederick M. Trieu, Calvin Vromen, Ellen M. et al.

Quelle: JAMA Netw Open

Schlagwörter: Male, tau Proteins/cerebrospinal fluid, Middle Aged, Alzheimer Disease/cerebrospinal fluid diagnosis, Amyloid beta-Peptides/cerebrospinal fluid, Cognitive Dysfunction/cerebrospinal fluid, 80 and over, Disease Progression, Humans, Female, Biomarkers/cerebrospinal fluid, Longitudinal Studies, Peptide Fragments/cerebrospinal fluid, Aged, Original Investigation

Zugangs-URL: https://cris.maastrichtuniversity.nl/en/publications/5534e36a-cff6-4e5a-b75e-a5082489300d
https://doi.org/10.1001/jamanetworkopen.2025.19919
https://pure.amsterdamumc.nl/en/publications/73a3e060-dda9-4305-9b08-808092aa1a90
https://doi.org/10.1001/jamanetworkopen.2025.19919

Involvement of the choroid plexus in Alzheimer’s disease pathophysiology: findings from mouse and human proteomic studies: findings from mouse and human proteomic studies

Autoren: Delvenne, Aurore Vandendriessche, Charysse Gobom, Johan et al.

Weitere Verfasser: Delvenne, Aurore Vandendriessche, Charysse Gobom, Johan et al.

Quelle: Fluids Barriers CNS
Fluids and Barriers of the CNS, Vol 21, Iss 1, Pp 1-17 (2024)
Delvenne, A, Vandendriessche, C, Gobom, J, Burgelman, M, Dujardin, P, de Nolf, C, Tijms, B M, Teunissen, C E, Schindler, S E, Verhey, F, Ramakers, I, Martinez-Lage, P, Tainta, M, Vandenberghe, R, Schaeverbeke, J, Engelborghs, S, de Roeck, E, Popp, J, Peyratout, G, Tsolaki, M, Freund-Levi, Y, Lovestone, S, Streffer, J, Bertram, L, Blennow, K, Zetterberg, H, Visser, P J, Vandenbroucke, R E & Vos, S J B 2024, 'Involvement of the choroid plexus in Alzheimer’s disease pathophysiology : findings from mouse and human proteomic studies', FLUIDS AND BARRIERS OF THE CNS, vol. 21, no. 1, 58. https://doi.org/10.1186/s12987-024-00555-3
Fluids and barriers of the CNS, vol. 21, no. 1, pp. 58
Fluids and barriers of the CNS
Fluids and barriers of the CNS, 21(1):58
FLUIDS AND BARRIERS OF THE CNS

Schlagwörter: Proteomics, Male, Neurologi, Proteome, Proteome/metabolism, Choroid plexus, Amyloid-beta (A beta), Mice, Amyloid beta-Protein Precursor, VESSELS, Medicine and Health Sciences, Amyloid-β (Aβ), Choroid Plexus/metabolism, 11 Medical and Health Sciences, Amyloid beta-Protein Precursor/metabolism, Alzheimer's disease, 3. Good health, Cerebrospinal fluid, Neurology, Choroid Plexus/metabolism [MeSH], Female [MeSH], Amyloid beta-Protein Precursor/metabolism [MeSH], Mice, Inbred C57BL [MeSH], Proteomics [MeSH], Humans [MeSH], Animals [MeSH], Mice, Transgenic [MeSH], Mice [MeSH], Proteome/metabolism [MeSH], Male [MeSH], Research, Amyloid beta-Protein Precursor/genetics [MeSH], APP knock-in mice, Alzheimer Disease/metabolism [MeSH], Disease Models, Animal [MeSH], Alzheimer Disease/cerebrospinal fluid [MeSH], Alzheimer Disease/metabolism, Female, Life Sciences & Biomedicine, EXPRESSION, mice, Mice, Transgenic, Alzheimer Disease/cerebrospinal fluid, Animals, Humans, Disease Models, Animal, Amyloid beta-Protein Precursor/genetics, Mice, Inbred C57BL, proteomics, ADULT, Alzheimer Disease, RC346-429, CEREBROSPINAL-FLUID PRODUCTION, Science & Technology, Neurosciences, Biology and Life Sciences, 06 Biological Sciences, BARRIER, TRANSPORT, MODEL, 3209 Neurosciences, Choroid Plexus, Human medicine, Neurosciences & Neurology, Neurology. Diseases of the nervous system

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39020361
https://doaj.org/article/7c5db71c472645af80c01089faaa997c
https://research.vumc.nl/en/publications/4ebbb5b9-aad9-46a1-9dd6-15f4f2ba65ce
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_AA3F1D78EAA61
https://serval.unil.ch/resource/serval:BIB_AA3F1D78EAA6.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_AA3F1D78EAA6
https://repository.uantwerpen.be/docstore/d:irua:25008
https://hdl.handle.net/10067/2077110151162165141
https://repository.publisso.de/resource/frl:6502664
https://biblio.vub.ac.be/vubir/(c5b30523-9aee-4776-ac0b-e58c8aaceabf).html
https://biblio.ugent.be/publication/01J73Q3F0X36FE71EVFSQ5Q591/file/01J73QE2PV3X1NSY0FF7P9T9GT
http://doi.org/10.1186/s12987-024-00555-3
https://biblio.ugent.be/publication/01J73Q3F0X36FE71EVFSQ5Q591
http://hdl.handle.net/1854/LU-01J73Q3F0X36FE71EVFSQ5Q591
http://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-115207

Continuous β-Amyloid CSF/PET Imbalance Model to Capture Alzheimer Disease Heterogeneity

Autoren: Mastenbroek, Sophie E Sala, Arianna Vállez García, David et al.

Quelle: Neurology
Alzheimer's Disease Neuroimaging Initiative on behalf of the AMYPAD consortium 2024, 'Continuous β-Amyloid CSF/PET Imbalance Model to Capture Alzheimer Disease Heterogeneity', Neurology, vol. 103, no. 1, e209419, pp. e209419. https://doi.org/10.1212/WNL.0000000000209419
Mastenbroek, S E, Sala, A, Vállez García, D, Shekari, M, Salvadó, G, Lorenzini, L, Pieperhoff, L, Wink, A M, Lopes Alves, I, Wolz, R, Ritchie, C, Boada, M, Visser, P J, Bucci, M, Farrar, G, Hansson, O, Nordberg, A K, Ossenkoppele, R, Barkhof, F, Gispert, J D, Rodriguez-Vieitez, E & Collij, L E 2024, 'Continuous β-Amyloid CSF/PET Imbalance Model to Capture Alzheimer Disease Heterogeneity', Neurology, vol. 103, no. 1, e209419. https://doi.org/10.1212/WNL.0000000000209419

Schlagwörter: Male, Alzheimer Disease/diagnostic imaging, Cognitive Dysfunction/diagnostic imaging, Sciences de la santé humaine, Alzheimer Disease/cerebrospinal fluid, Cognitive Dysfunction/cerebrospinal fluid, Alzheimer Disease, Neurologie, 80 and over, Humans, Biomarkers/cerebrospinal fluid, Cognitive Dysfunction, Human health sciences, Aged, Aged, 80 and over, Amyloid beta-Peptides, Cognitive Dysfunction/cerebrospinal fluid diagnostic imaging, Middle Aged, amyloid beta-protein (1-42), Amyloid beta-Peptides/cerebrospinal fluid, Peptide Fragments, 3. Good health, Neurology, Positron-Emission Tomography, Alzheimer Disease/cerebrospinal fluid diagnostic imaging, Female, Neurology (clinical), Peptide Fragments/cerebrospinal fluid, Biomarkers, Research Article

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38862136
https://cris.maastrichtuniversity.nl/en/publications/d2e25fd8-72d3-4930-a177-cc7bd6c41711
https://doi.org/10.1212/WNL.0000000000209419
https://research.vumc.nl/en/publications/a93d69af-47f4-448e-a785-69feb14d2a47
https://research.vumc.nl/en/publications/bea3d6cf-1df1-4dcb-8bcb-c7c5257bec4b
https://research.vumc.nl/en/publications/fbfdde7e-f9fd-464c-9dde-81fb23ac2256
https://research.vumc.nl/en/publications/b4a28812-a00f-4f6b-8398-aae998daf717
https://research.vumc.nl/en/publications/c7168a45-f689-487a-aeca-120ab3237447
https://research.vumc.nl/en/publications/a67a984d-e1fe-4ecc-a40a-1f49ce6421c6
https://research.vumc.nl/en/publications/45892d04-1317-4b12-b2a6-6234119ce0b8
https://hdl.handle.net/2268/325058
https://doi.org/10.1212/WNL.0000000000209419

The effects of mosaicism on biological and clinical markers of Alzheimer's disease in adults with Down syndrome

Autoren: Xicota, Laura Dang, Lam-Ha T. Lee, Alice et al.

Quelle: EBioMedicine

Schlagwörter: Alzheimer's disease, CSF, Down syndrome, mosaicism, PET, plasma biomarkers, Down Syndrome / genetics, Down Syndrome / complications, Down Syndrome / diagnosis, Alzheimer Disease / genetics, Alzheimer Disease / blood, Alzheimer Disease / diagnosis, Alzheimer Disease / cerebrospinal fluid, Biomarkers, Amyloid beta, Peptides / cerebrospinal fluid, Amyloid beta-Peptides / blood, tau Proteins / cerebrospinal fluid, tau Proteins / genetics

Dateibeschreibung: application/pdf

Relation: https://doi.org/10.1016/j.ebiom.2024.105433; https://hdl.handle.net/20.500.12503/33045; 110

Verfügbarkeit: https://hdl.handle.net/20.500.12503/33045

Data-driven CSF biomarker profiling: imaging and clinical outcomes in a cohort at risk of Alzheimer’s disease

Autoren: Argiris, Georgette Akinci, Muge Peña-Gómez, Cleofé et al.

Weitere Verfasser: Argiris, Georgette Akinci, Muge Peña-Gómez, Cleofé et al.

Quelle: Alzheimers Res Ther
Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-15 (2024)

Schlagwörter: Male, Amyloid beta-Peptides, β-amyloid, Research, Neurosciences. Biological psychiatry. Neuropsychiatry, tau Proteins, Sporadic Alzheimer's disease, Middle Aged, Magnetic Resonance Imaging, Hierarchical clustering, Peptide Fragments, Cohort Studies, Alzheimer Disease, Female [MeSH], Aged [MeSH], Humans [MeSH], CSF biomarkers, Alzheimer Disease/diagnostic imaging [MeSH], Middle Aged [MeSH], Amyloid beta-Peptides/cerebrospinal fluid [MeSH], Cohort Studies [MeSH], Magnetic Resonance Imaging [MeSH], ALFA cohort, Biomarkers/cerebrospinal fluid [MeSH], Male [MeSH], Positron-Emission Tomography [MeSH], Peptide Fragments/cerebrospinal fluid [MeSH], tau Proteins/cerebrospinal fluid [MeSH], ATN, Alzheimer Disease/cerebrospinal fluid [MeSH], Positron-Emission Tomography, Humans, Female, Neurology. Diseases of the nervous system, RC346-429, Biomarkers, RC321-571, Aged

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39716329
https://doaj.org/article/910622b74ed84c4290cac0ddb3e7c3d1
https://repository.publisso.de/resource/frl:6504707

Association of Vascular Risk Factors and Cerebrovascular Pathology With Alzheimer Disease Pathologic Changes in Individuals Without Dementia

Autoren: Luigi Lorenzini Alessio Maranzano Silvia Ingala et al.

Weitere Verfasser: Luigi Lorenzini Alessio Maranzano Silvia Ingala et al.

Quelle: Neurology
Neurology 103(7), e209801 (2024). doi:10.1212/WNL.0000000000209801

Schlagwörter: Male, [SDV]Life Sciences [q-bio], cerebrospinal fluid [Amyloid beta-Peptides], MESH: Magnetic Resonance Imaging, pathology [Alzheimer Disease], SMALL VESSEL DISEASE, MESH: Risk Factors, pathology [Brain], Risk Factors, MESH: Amyloid beta-Peptides / cerebrospinal fluid, TAU PATHOLOGY, MESH: Aged, pathology [Atrophy], MESH: Middle Aged, MESH: Alzheimer Disease / cerebrospinal fluid, Brain, MESH: Peptide Fragments / cerebrospinal fluid, Middle Aged, amyloid beta-protein (1-42), AMYLOID-BETA, Magnetic Resonance Imaging, cerebrospinal fluid [Alzheimer Disease], HYPERINTENSITIES, cerebrospinal fluid [Biomarkers], complications [Cerebral Small Vessel Diseases], MESH: Brain / diagnostic imaging, Female, diagnostic imaging [Cerebral Small Vessel Diseases], Neurovetenskaper, MESH: Biomarkers / cerebrospinal fluid, MRI, Research Article, Geriatrik, tau Proteins, MESH: Cerebral Small Vessel Diseases / pathology, MESH: Alzheimer Disease / pathology, Alzheimer Disease, Humans, ddc:610, cerebrospinal fluid [Peptide Fragments], diagnostic imaging [Brain], MESH: Cerebral Small Vessel Diseases / diagnostic imaging, Aged, Retrospective Studies, MESH: tau Proteins / cerebrospinal fluid, MESH: Humans, Amyloid beta-Peptides, MESH: Alzheimer Disease / diagnostic imaging, Neurosciences, MESH: Retrospective Studies, MESH: Male, Peptide Fragments, MESH: Atrophy / pathology, cerebrospinal fluid [tau Proteins], Geriatrics, Cerebral Small Vessel Diseases, pathology [Cerebral Small Vessel Diseases], MESH: Brain / pathology, Atrophy, MESH: Cerebral Small Vessel Diseases / complications, MESH: Female, diagnostic imaging [Alzheimer Disease], Biomarkers

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39288341
https://cris.maastrichtuniversity.nl/en/publications/764fc581-eb05-4df4-a52c-bf068d12f39f
https://doi.org/10.1212/WNL.0000000000209801
https://pub.dzne.de/record/272157
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-540158

Association of oxidative stress and inflammatory metabolites with Alzheimer’s disease cerebrospinal fluid biomarkers in mild cognitive impairment

Autoren: Ahmad, S. Yang, W. Orellana, A. et al.

Quelle: Alzheimers Res Ther
Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-13 (2024)
Alzheimer's research & therapy 16(1), 171 (2024). doi:10.1186/s13195-024-01542-4

Schlagwörter: Male, 0301 basic medicine, Prostaglandin, Cognitive Dysfunction/cerebrospinal fluid [MeSH], Disease Progression [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Isoprostane, Cerebrospinal fluid, Amyloid beta-Peptides/cerebrospinal fluid [MeSH], Alzheimer's disease, Oxidative Stress/physiology [MeSH], Male [MeSH], Metabolomics/methods [MeSH], tau Proteins/cerebrospinal fluid [MeSH], Female [MeSH], Humans [MeSH], Middle Aged [MeSH], Oxidative stress, Prostaglandins/cerebrospinal fluid [MeSH], Biomarkers/cerebrospinal fluid [MeSH], Isoprostanes/cerebrospinal fluid [MeSH], Research, Peptide Fragments/cerebrospinal fluid [MeSH], Mild cognitive impairment, Inflammation/cerebrospinal fluid [MeSH], Alzheimer Disease/cerebrospinal fluid [MeSH], Neurosciences. Biological psychiatry. Neuropsychiatry, tau Proteins, cerebrospinal fluid [Amyloid beta-Peptides], cerebrospinal fluid [Prostaglandins], Isoprostanes, physiology [Oxidative Stress], 03 medical and health sciences, 0302 clinical medicine, Alzheimer Disease, Humans, Metabolomics, Cognitive Dysfunction, ddc:610, cerebrospinal fluid [Peptide Fragments], RC346-429, cerebrospinal fluid [Isoprostanes], Aged, Inflammation, Aged, 80 and over, Amyloid beta-Peptides, Middle Aged, amyloid beta-protein (1-42), Peptide Fragments, methods [Metabolomics], 3. Good health, cerebrospinal fluid [Cognitive Dysfunction], cerebrospinal fluid [Alzheimer Disease], cerebrospinal fluid [Inflammation], Oxidative Stress, cerebrospinal fluid [Biomarkers], cerebrospinal fluid [tau Proteins], Disease Progression, Prostaglandins, Female, Neurology. Diseases of the nervous system, APOE, Biomarkers, RC321-571

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39080778
https://doaj.org/article/43de45b042744c0e9c80620804e9b560
https://pub.dzne.de/record/271075
https://repository.publisso.de/resource/frl:6501450
https://hdl.handle.net/1887/4198580

Synaptic protein CSF levels relate to memory scores in individuals without dementia

Autoren: Kirsten E. J. Wesenhagen Diederick M. de Leeuw Jori Tomassen et al.

Weitere Verfasser: Kirsten E. J. Wesenhagen Diederick M. de Leeuw Jori Tomassen et al.

Quelle: Alzheimers Res Ther
Res Sq
Alzheimer’s Research & Therapy, Vol 17, Iss 1, Pp 1-15 (2025)
Alzheimer's research & therapy, vol. 17, no. 1, pp. 56
Alzheimer's research & therapy
Alzheimer's Research & Therapy

Schlagwörter: Male, MILD COGNITIVE IMPAIRMENT, Early Alzheimer's disease, PROGRESSION, Neurosciences. Biological psychiatry. Neuropsychiatry, early Alzheimer's disease, Neuropsychological Tests, ASTROCYTES, Article, Synaptic proteins, OLIGOMERS, Alzheimer Disease, Memory, Humans, Cognitive Dysfunction, RC346-429, memory performance, Aged, Aged, 80 and over, cerebrospinal fluid proteomics, DECLINE, Memory Disorders, Amyloid beta-Peptides, Research, ASSOCIATION, Cerebrospinal fluid proteomics, Middle Aged, AMYLOID-BETA, NEUROGRANIN, ALZHEIMERS-DISEASE, Memory performance, Female, Human medicine, Neurology. Diseases of the nervous system, TAU, Cognitive Dysfunction/cerebrospinal fluid, Cognitive Dysfunction/psychology, Biomarkers/cerebrospinal fluid, Alzheimer Disease/cerebrospinal fluid, Memory Disorders/cerebrospinal fluid, Memory Disorders/etiology, Memory/physiology, Synapses, Biomarkers, RC321-571

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39108495
https://pubmed.ncbi.nlm.nih.gov/40033427
https://doaj.org/article/47b19da867c743579995709d704bfaee
https://hdl.handle.net/1871.1/b6ecb675-6d39-4a1a-a1e9-391d02422021
https://doi.org/10.1186/s13195-025-01703-z
https://research.vu.nl/en/publications/b6ecb675-6d39-4a1a-a1e9-391d02422021
https://pure.amsterdamumc.nl/en/publications/87c6ac52-cbdf-47ac-a371-10530f1fa492
https://doi.org/10.1186/s13195-025-01703-z
https://ora.ox.ac.uk/objects/uuid:c2768b46-6c36-496f-a139-d992405922a6
https://doi.org/10.1186/s13195-025-01703-z
https://serval.unil.ch/resource/serval:BIB_FFC5500F5D01.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_FFC5500F5D015
https://serval.unil.ch/notice/serval:BIB_FFC5500F5D01
https://hdl.handle.net/10067/2133240151162165141
https://repository.uantwerpen.be/docstore/d:irua:28131

Effects of time of the day at sampling on CSF and plasma levels of Alzheimer’ disease biomarkers

Autoren: Orduña Dolado, Anna Stomrud, Erik Ashton, Nicholas J. et al.

Quelle: Alzheimers Res Ther
Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-10 (2024)

Schlagwörter: Male, 0301 basic medicine, Fluid biomarkers, Neurosciences. Biological psychiatry. Neuropsychiatry, tau Proteins, p-tau, 03 medical and health sciences, 0302 clinical medicine, Alzheimer Disease, Neurofilament Proteins, Glial Fibrillary Acidic Protein, Humans, RC346-429, Aβ, Aged, Aged, 80 and over, Amyloid beta-Peptides, Research, Alzheimer Disease/blood [MeSH], Neurofilament Proteins/cerebrospinal fluid [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Amyloid beta-Peptides/cerebrospinal fluid [MeSH], Alzheimer Disease/diagnosis [MeSH], Alzheimer's disease, Male [MeSH], Neurofilament Proteins/blood [MeSH], Glial Fibrillary Acidic Protein/cerebrospinal fluid [MeSH], Peptide Fragments/blood [MeSH], Circadian Rhythm/physiology [MeSH], Diurnal variability, tau Proteins/blood [MeSH], tau Proteins/cerebrospinal fluid [MeSH], Female [MeSH], Biomarkers/blood [MeSH], Humans [MeSH], Sampling time, Glial Fibrillary Acidic Protein/blood [MeSH], Middle Aged [MeSH], Biomarkers/cerebrospinal fluid [MeSH], Peptide Fragments/cerebrospinal fluid [MeSH], Amyloid beta-Peptides/blood [MeSH], Alzheimer Disease/cerebrospinal fluid [MeSH], Middle Aged, 16. Peace & justice, Peptide Fragments, Circadian Rhythm, 3. Good health, Female, Neurology. Diseases of the nervous system, Biomarkers, RC321-571

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38909218
https://doaj.org/article/f78a34bbdde94bdab236ffea02e7059b
https://repository.publisso.de/resource/frl:6504191

Can Small Molecules Provide Clues on Disease Progression in Cerebrospinal Fluid from Mild Cognitive Impairment and Alzheimer's Disease Patients?

Autoren: TALAVERA ANDUJAR, Begona MARY, Arnaud VENEGAS MALDONADO, Carmen Jesica et al.

Quelle: Environmental Science and Technology, 58 (9), 4181 - 4192 (2024-03-05)

Schlagwörter: bile acids, cheminformatics, exposomics, high-resolution mass spectrometry, liquid chromatography, metabolomics, tau Proteins, Amyloid beta-Peptides, Biomarkers, Humans, tau Proteins/cerebrospinal fluid, Amyloid beta-Peptides/cerebrospinal fluid, Pilot Projects, Disease Progression, Alzheimer Disease/cerebrospinal fluid, Alzheimer Disease/diagnosis, Alzheimer Disease/psychology, Neurodegenerative Diseases, Cognitive Dysfunction/cerebrospinal fluid, Cognitive Dysfunction/diagnosis, Cognitive Dysfunction/psychology, Alzheimers disease, Bile acid, Clinical symptoms, Cognitive impairment, Exposomic, High resolution mass spectrometry, Small molecules, Alzheimer Disease, Cognitive Dysfunction

Relation: urn:issn:0013-936X; urn:issn:1520-5851; https://orbilu.uni.lu/handle/10993/62427; info:hdl:10993/62427; info:pmid:38373301; wos:001166933900001

Verfügbarkeit: https://orbilu.uni.lu/handle/10993/62427
https://orbilu.uni.lu/bitstream/10993/62427/1/talavera-and%c3%bajar-et-al-2024-can-small-molecules-provide-clues-on-disease-progression-in-cerebrospinal-fluid-from-mild.pdf
https://doi.org/10.1021/acs.est.3c10490

Alzheimer’s Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus: Linking Functional Connectivity and Clinical Outcome

Autoren: Valentina Garibotto Giulia Bommarito Federica Ribaldi et al.

Quelle: Journal of Alzheimer's disease, Vol. 83, No 4 (2021) pp. 1717-1728

Schlagwörter: Male, Amyloid, 616.8, tau Proteins, Tau Proteins / cerebrospinal fluid, ddc:616.0757, Hippocampus, Alzheimer Disease / complications, 618.97, Functional connectivity, Alzheimer Disease / cerebrospinal fluid, 03 medical and health sciences, 0302 clinical medicine, Hydrocephalus, Normal Pressure / cerebrospinal fluid, Alzheimer Disease, Humans, Aged, Amyloid beta-Peptides, 616.0757, Normal pressure hydrocephalus, Default Mode Network, Amyloid beta-Peptides / cerebrospinal fluid, Hydrocephalus, Normal Pressure, Peptide Fragments, ddc:616.8, 3. Good health, Peptide Fragments / cerebrospinal fluid, CSF tap test, ddc:618.97, Default mode network, Female, Tau, Biomarkers / cerebrospinal fluid, Hydrocephalus, Normal Pressure / complications, Alzheimer's disease, Biomarkers

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/34459399
https://infoscience.epfl.ch/record/289931
https://content.iospress.com/articles/journal-of-alzheimers-disease/jad210534
https://europepmc.org/article/MED/34459399
https://pubmed.ncbi.nlm.nih.gov/34459399/
https://www.ncbi.nlm.nih.gov/pubmed/34459399
https://archive-ouverte.unige.ch/unige:160666

The Association of Essential Metals with APOE Genotype in Alzheimer’s Disease

Autoren: Babić Leko, Mirjana Jurasović, Jasna Nikolac Perković, Matea et al.

Quelle: Journal of Alzheimer's Disease. 82:661-672

Schlagwörter: Male, Alzheimer Disease* / cerebrospinal fluid, Genotype, Apolipoprotein E4, metals, Alzheimer's disease, apolipoprotein E, copper, mild cognitive impairment, zinc, Biological Transport / physiology, Metals* / blood, 03 medical and health sciences, Apolipoproteins E, 0302 clinical medicine, Zinc / cerebrospinal fluid, Alzheimer Disease, Alzheimer Disease* / blood, Humans, Cognitive Dysfunction, Cholesterol / metabolism, Correlation of Data, Cognitive Dysfunction / blood, Sodium / blood, Aged, Metalloids, Sodium, Metals* / cerebrospinal fluid, Biological Transport, Cognitive Dysfunction / diagnosis, 3. Good health, Ferritins / cerebrospinal fluid, Zinc, Cholesterol, Metals, Ferritins, Metals* / classification, Metalloids* / blood, Apolipoprotein E4 / genetics, Cognitive Dysfunction / cerebrospinal fluid, Female, Alzheimer Disease* / genetics, Metalloids* / cerebrospinal fluid

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/34057084
https://www.bib.irb.hr/1131540
https://doi.org/10.3233/jad-210158
https://pubmed.ncbi.nlm.nih.gov/34057084/
https://doi.org/10.3233/JAD-210158
https://www.bib.irb.hr/1131540
https://pubmed.ncbi.nlm.nih.gov/34057084/
https://www.ncbi.nlm.nih.gov/pubmed/34057084
https://europepmc.org/article/MED/34057084
https://content.iospress.com/articles/journal-of-alzheimers-disease/jad210158

White Matter Hyperintensities Are No Major Confounder for Alzheimer’s Disease Cerebrospinal Fluid Biomarkers

Autoren: Van Waalwijk Van Doorn L. J. C. Ghafoorian M. Van Leijsen E. M. C. et al.

Weitere Verfasser: Van Waalwijk Van Doorn L. J. C. Ghafoorian M. Van Leijsen E. M. C. et al.

Quelle: J Alzheimers Dis
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
JOURNAL OF ALZHEIMERS DISEASE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Fundacion Sancho el Sabio Fundazioa (FSS)
Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
Journal of Alzheimer's Disease, 79, 1, pp. 163-175

Schlagwörter: Male, Alzheimer Disease / diagnosis, Tau Proteins / cerebrospinal fluid, Leukoencephalopathies / cerebrospinal fluid, tau proteins, 618.97, 0302 clinical medicine, Leukoencephalopathies, White matter hyperintensities, Image Processing, Computer-Assisted, magnetic resonance imaging, Phosphorylation, amyloid, Amyloid beta-Peptides / cerebrospinal fluid, Confounding Factors, Epidemiologic, white matter hyperintensities, Alzheimer's disease, Middle Aged, Magnetic Resonance Imaging, 3. Good health, Leukoencephalopathies / diagnostic imaging, Cerebrospinal fluid, Peptide Fragments / cerebrospinal fluid, biomarkers, cerebrospinal fluid, white matter lesions, Radboudumc 1: Alzheimer's disease DCMN: Donders Center for Medical Neuroscience, Female, Research Article, Amyloid, Radboud University Medical Center, tau Proteins, White matter lesions, Alzheimer Disease / cerebrospinal fluid, 03 medical and health sciences, Magnetic resonance imaging, Alzheimer Disease, Tau proteins, Humans, Cognitive Dysfunction, Aged, Amyloid beta-Peptides, Neurology - Radboud University Medical Center, Radboudumc 3: Disorders of movement DCMN: Donders Center for Medical Neuroscience, Cognitive Dysfunction / diagnosis, Peptide Fragments, Laboratory Medicine - Radboud University Medical Center, Cognitive Dysfunction / cerebrospinal fluid, Biomarkers

Dateibeschreibung: application/pdf

Zugangs-URL: https://ddd.uab.cat/pub/artpub/2021/pmc_33252070/pmc_33252070.pdf
https://pubmed.ncbi.nlm.nih.gov/33252070
https://ddd.uab.cat/record/238669
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4178
http://ddd.uab.cat/record/238669
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4178
https://content.iospress.com/articles/journal-of-alzheimers-disease/jad200496
https://www.ncbi.nlm.nih.gov/pubmed/33252070
https://publicatt.unicatt.it/handle/10807/167534
https://pubmed.ncbi.nlm.nih.gov/33252070/
https://repository.ubn.ru.nl/handle/2066/230119
https://moh-it.pure.elsevier.com/en/publications/white-matter-hyperintensities-are-no-major-confounder-for-alzheim
https://hdl.handle.net/2066/230119
https://repository.ubn.ru.nl//bitstream/handle/2066/230119/230119.pdf

Persisting neuropsychiatric symptoms, Alzheimer’s disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate

Autoren: Ouanes, Sami Rabl, Miriam Clark, Christopher et al.

Weitere Verfasser: Ouanes, Sami Rabl, Miriam Clark, Christopher et al.

Quelle: Alzheimers Res Ther
Alzheimer’s Research & Therapy, Vol 14, Iss 1, Pp 1-12 (2022)
Alzheimer's research & therapy, vol. 14, no. 1, pp. 190

Schlagwörter: 2805 Cognitive Neuroscience, Hypothalamo-Hypophyseal System, Hydrocortisone, Pituitary-Adrenal System, 610 Medicine & health, Neurosciences. Biological psychiatry. Neuropsychiatry, Neuropsychological Tests, Cortisol, Dehydroepiandrosterone sulfate, 03 medical and health sciences, 0302 clinical medicine, Alzheimer Disease, Humans, Cognitive Dysfunction, Prospective Studies, RC346-429, Dehydroepiandrosterone Sulfate, Research, Neuropsychiatric symptoms, 3. Good health, 2728 Neurology (clinical), Cerebrospinal fluid, 10054 Clinic for Psychiatry, Psychotherapy, and Psychosomatics, 2808 Neurology, Alzheimer Disease/cerebrospinal fluid, Hydrocortisone/cerebrospinal fluid, Cognitive Dysfunction/diagnosis, Dementia, Biomarkers/cerebrospinal fluid, Alzheimer's disease, Behavioral and psychological symptoms of dementia, Biomarkers, Neurology. Diseases of the nervous system, RC321-571

Dateibeschreibung: application/pdf; s13195_022_01139_9.pdf - application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/36529757
https://doaj.org/article/3b8af2572b7f4cec8529d98b182096a5
https://serval.unil.ch/resource/serval:BIB_7F388AFE5B07.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_7F388AFE5B071
https://serval.unil.ch/notice/serval:BIB_7F388AFE5B07
https://www.zora.uzh.ch/id/eprint/228998/
https://doi.org/10.5167/uzh-228998